Valgan

Valgan, manufactured by Cipla, is a potent prescription antiviral medication primarily formulated to treat Cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). It is also highly effective in preventing CMV disease in high-risk solid organ transplant recipients, such as kidney, heart, and kidney-pancreas transplant patients. Once ingested, the active ingredient rapidly converts into ganciclovir, which aggressively halts viral DNA synthesis and replication. This targeted mechanism protects vital organs and vision from viral deterioration. Due to its strong clinical profile, strict adherence to a healthcare provider’s dosing schedule and regular laboratory monitoring are essential.